...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Nonprofit Think Tank

At the very least, I want to see this trading on an American board. Better yet, I want to see this in play!!!

Don't know if Don gets this yet, so let's cut him some IOUs on the annual salary going forward! Then he can share OUR pain a little more!

Share
New Message
Please login to post a reply